Skip to main content
. 2014 May 28;24(6):599–606. doi: 10.1111/bpa.12146

Figure 4.

figure

Mapping of the severity and extent of neuronal loss, gliosis and 1 C 2‐immunoreactive frequency (1 C2‐IF ) in three patients withSCA 2. The severity and extent of neuronal loss and gliosis increased almost in parallel with the 1C2‐IF.